查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
空间基因组学/空间转录组学市场规模、份额和趋势分析报告：按技术、产品、最终用途、区域和细分趋势：2023-2030
市场调查报告书
商品编码
1321346

空间基因组学/空间转录组学市场规模、份额和趋势分析报告：按技术、产品、最终用途、区域和细分趋势：2023-2030

Spatial Genomics & Transcriptomics Market Size, Share & Trends Analysis Report By Technology (Spatial Transcriptomics, Spatial Genomics), By Product (Consumables, Software), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

空间基因组学和空间转录组学市场的增长和趋势

Grand View Research 的最新报告显示，到 2030 年，全球空间基因组学和转录组学市场预计将达到 5.743 亿美元。

预计2023年至2030年该市场将以12.2%的年复合成长率增长。由于空间基因组分析作为癌症检测方法的潜力不断增加以及最新一代测序技术的出现，市场有望在预测期内出现显着增长。

向个性化医疗的转变，旨在根据个体特征提供定制医疗护理，增加了对空间基因组学和空间转录组学的需求。这些技术可以全面了解患者组织内的遗传和分子状况，从而实现准确的诊断、预后和治疗选择。空间基因组学和转录组学有助于识别与疾病亚型相关的特定基因表现模式，使临床医生能够就个体化治疗策略做出资讯的决定。

近年来，空间基因组学和空间转录组学市场取得了显着的技术进步。公司投资于研发，以提高空间基因组学和空间转录组学平台的准确性、可扩展性和可承受性。此外，市场还推出了用户友好的整合解决方案，可简化资料分析和解释，使这些技术可供更广泛的用户群使用。

例如，2023年4月，Vizgen宣布推出全球首个基于MERFISH技术的单细胞空间基因组学平台。该仪器为转录组分析提供高解析度和最高效率。这些进步正在扩大市场潜力并吸引学术界和工业界的投资。

空间基因组学/空间转录组学市场报告亮点

  • 空间转录组学技术领域在 2022 年占据最大的收入份额，因为与单细胞转录组学研究中的空间基因组学方法相比，空间转录组学技术的采用率更高。
  • 消耗品领域预计在预测期内将以最快的年复合成长率增长，因为它涵盖了在基因组作图各个阶段（从样品製备到结果推导）运作仪器所需的产品。
  • 2022 年，转化研究领域的收入份额最高。因为在转化研究中使用空间组学技术可以通过提供对生理学和疾病状态的彻底分析来使研究受益。
  • 由于中国和印度等新兴经济体存在未开发的机会，预计亚太地区在预测期内将以最快的年复合成长率增长。
  • 主要市场参与者包括 Natera Inc.、10x Genomics、Dovetail Genomics、Illumina, Inc. 和 S2 Genomics, Inc.。

目录

第1章调查方法和范围

  • 市场区隔和范围
  • 市场定义
  • 研究假设
  • 资讯采购
  • 资讯或资料分析
  • 市场形成和检验
  • 市场模式
  • 全球市场：计算年复合成长率
  • 目的

第2章执行摘要

第3章市场变量、趋势和范围

  • 市场体系预测
    • 母公司市场预测
    • 相关/附市场预测
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 行业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影响分析

第4章科技业务分析

  • 空间基因组学/空间转录组学市场：技术波动分析
  • 空间转录组学
    • 全球空间转录组学市场，2018-2030
    • 基于序列的方法
    • IHC
    • 基于显微镜的 RNA 成像技术
  • 空间基因组学
    • 全球空间基因组学市场，2018-2030
    • FISH
    • 基于显微镜的 DNA 实时成像
    • 基因组扰动工具
    • 大规模并行序列
    • 生化方法
    • 其他的

第5章产品经营分析

  • 空间基因组学/空间转录组学市场：产品变异分析
  • 设备
  • 消耗品
  • 软件

第6章最终用途业务分析

  • 空间基因组学和空间转录组学市场：最终用途变异分析
  • 转化研究
  • 学术客户
  • 诊断客户
  • 药品製造商

第7章区域业务分析

  • 2022 年和 2030 年按地区分類的空间基因组学和空间转录组学市场份额
  • 北美
    • SWOT分析
    • 空间基因组学和空间转录组学市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • SWOT分析
    • 空间基因组学和空间转录组学市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • SWOT分析
    • 空间基因组学和空间转录组学市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 鲷鱼
    • 韩国
  • 拉美
    • SWOT分析
    • 空间基因组学和空间转录组学市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • SWOT分析
    • 空间基因组学和空间转录组学市场，2018-2030
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第8章竞争形势

  • 企业分类
  • 战略规划
  • 2022 年公司市场份额分析
  • 公司简介/名单
    • Natera, Inc.
    • 10x Genomics
    • Dovetail Genomics
    • Illumina, Inc.
    • S2 Genomics, Inc.
    • Nanostring Technologies, Inc.
    • Seven Bridges Genomics
    • Horizon Discovery Group plc
    • Bio-Techne
Product Code: GVR-3-68038-220-4

Spatial Genomics & Transcriptomics Market Growth & Trends

The global spatial genomics & transcriptomics market size is expected to reach USD 574.3 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 12.2% from 2023 to 2030. The market is poised for significant growth over the forecast period owing to the increasing potential of spatial genomic analysis as a cancer detection method and the advent of the latest generation of sequencing technology.

The shift toward personalized medicine, which aims to provide tailored healthcare based on individual characteristics, is driving the demand for spatial genomics and transcriptomics. These technologies offer a comprehensive view of the genetic and molecular landscape within patient tissues, enabling precise diagnosis, prognosis, and treatment selection. Spatial genomics and transcriptomics facilitate the identification of specific gene expression patterns associated with disease subtypes, allowing clinicians to make informed decisions about personalized treatment strategies.

The market for spatial genomics & transcriptomics has witnessed significant technological advancements in recent years. Companies have been investing in research and development to improve the accuracy, scalability, and affordability of spatial genomics and transcriptomics platforms. Additionally, the market has seen the introduction of user-friendly and integrated solutions that simplify data analysis and interpretation, making these technologies more accessible to a broader user base.

For instance, in April 2023, Vizgen launched the world's first single-cell spatial genomics platform based on MERFISH technology. The device offers high resolution and maximum efficiency to profile the transcriptome. These advancements have expanded the market potential and attracted investments from both academic and industry sectors.

Spatial Genomics & Transcriptomics Market Report Highlights

  • The spatial transcriptomics technology segment accounted for the largest revenue share in 2022, owing to their high adoption as compared to spatial genomic methods, for the transcriptomic study of single cells
  • The consumables segment is expected to grow at the fastest CAGR during the forecast period, as this segment covers products that are required to run the instruments across various stages of genome mapping from sample preparation to result derivation
  • The translational research segment accounted for the highest revenue share in 2022, because the use of spatial omics technologies in translational research may potentially benefit research by providing a thorough analysis of physiology & state of a disease
  • Asia Pacific is anticipated to be growing at the fastest CAGR over the forecast period due to the presence of untapped opportunities in the emerging economies of China and India
  • A few major market players include Natera Inc.; 10x Genomics; Dovetail Genomics; Illumina, Inc.; and S2 Genomics, Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objective
    • 1.9.1. Objective 1
    • 1.9.2. Objective2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Emerging potential of spatial genomic analysis as a cancer diagnostic tool
      • 3.2.1.2. Advent of the fourth generation of sequencing (in situ sequencing)
      • 3.2.1.3. Emerging players can boost the market competitiveness
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Slow implementation of technology
      • 3.2.2.2. Well-established workflows for conventional genomics & transcriptomics analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Spatial Genomics & Transcriptomics Market: Technology Movement Analysis
  • 4.2. Spatial Transcriptomics
    • 4.2.1. Global Spatial Transcriptomics Market, 2018 - 2030 (USD Million)
    • 4.2.2. Sequencing-based methods
      • 4.2.2.1. Global sequencing-based methods Market, 2018 - 2030 (USD Million)
      • 4.2.2.2. Laser Capture Microdissection (LCM)
      • 4.2.2.2.1. Global LCM market for spatial transcriptomics, 2018 - 2030 (USD Million)
      • 4.2.2.2.2. LCM using FFPE Tissue Samples
      • 4.2.2.2.2.1. Global FFPE tissue samples-based LCM market for spatial transcriptomics, 2018 - 2030 (USD Million)
      • 4.2.2.2.3. LCM using other Tissue Samples
      • 4.2.2.2.3.1. Global other tissue samples-based LCM market for spatial transcriptomics, 2018 - 2030 (USD Million)
      • 4.2.2.3. Transcriptome In-vivo Analysis (TIVA)
      • 4.2.2.3.1. Global TIVA market for spatial transcriptomics, 2018 - 2030 (USD Million)
      • 4.2.2.4. In situ sequencing
      • 4.2.2.4.1. Global In situ sequencing market for spatial transcriptomics, 2018 - 2030 (USD Million)
      • 4.2.2.5. Microtomy sequencing
      • 4.2.2.5.1. Global microtomy sequencing market for spatial transcriptomics, 2018 - 2030 (USD Million)
    • 4.2.3. IHC
      • 4.2.3.1. Global IHC Market, 2018 - 2030 (USD Million)
    • 4.2.4. Microscopy-based RNA imaging techniques
      • 4.2.4.1. Global microscopy-based RNA imaging techniques Market, 2018 - 2030 (USD Million)
      • 4.2.4.2. Single Molecule RNA fluorescence In-Situ Hybridization (smFISH)
      • 4.2.4.2.1. Global Single Molecule RNA fluorescence In-Situ Hybridization (smFISH) market for spatial transcriptomics, 2018 - 2030 (USD Million)
      • 4.2.4.3. Padlock Probes/Rolling Circle Amplification
      • 4.2.4.3.1. Global Padlock Probes/Rolling Circle Amplification market for spatial transcriptomics, 2018 - 2030 (USD Million)
      • 4.2.4.4. Branched DNA Probes
      • 4.2.4.4.1. Global Branched DNA probes market for spatial transcriptomics, 2018 - 2030 (USD Million)
  • 4.3. Spatial Genomics
    • 4.3.1. Global spatial genomics Market, 2018 - 2030 (USD Million)
    • 4.3.2. FISH
      • 4.3.2.1. Global FISH Market for spatial genomics, 2018 - 2030 (USD Million)
    • 4.3.3. Microscopy-based Live DNA Imaging
      • 4.3.3.1. Global Microscopy-based Live DNA Imaging Market for spatial genomics, 2018 - 2030 (USD Million)
    • 4.3.4. Genome Perturbation tools
      • 4.3.4.1. Global genome perturbation tools Market for spatial genomics, 2018 - 2030 (USD Million)
    • 4.3.5. Massively-Parallel Sequencing
      • 4.3.5.1. Global massively-parallel sequencing Market for spatial genomics, 2018 - 2030 (USD Million)
    • 4.3.6. Biochemical Techniques
      • 4.3.6.1. Global biochemical techniques Market for spatial genomics, 2018 - 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Global others Market for spatial genomics, 2018 - 2030 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Spatial Genomics & Transcriptomics Market: Product Movement Analysis
  • 5.2. Instruments
    • 5.2.1. Global Instruments Market for Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)
    • 5.2.2. By Mode
      • 5.2.2.1. Automated
      • 5.2.2.1.1. Global automated Market, 2018 - 2030 (USD Million)
      • 5.2.2.2. Semi-Automated
      • 5.2.2.2.1. Global semi-automated Market, 2018 - 2030 (USD Million)
      • 5.2.2.3. Manual
      • 5.2.2.3.1. Global manual Market, 2018 - 2030 (USD Million)
    • 5.2.3. By Type
      • 5.2.3.1. Sequencing Platforms
      • 5.2.3.1.1. Global sequencing platforms Market, 2018 - 2030 (USD Million)
      • 5.2.3.2. IHC
      • 5.2.3.2.1. Global IHC Market, 2018 - 2030 (USD Million)
      • 5.2.3.3. Microscopy
      • 5.2.3.3.1. Global microscopy Market, 2018 - 2030 (USD Million)
      • 5.2.3.4. Flow Cytometry
      • 5.2.3.4.1. Global flow cytometry Market, 2018 - 2030 (USD Million)
      • 5.2.3.5. Mass Spectrometry
      • 5.2.3.5.1. Global mass spectrometry Market, 2018 - 2030 (USD Million)
      • 5.2.3.6. Others
      • 5.2.3.6.1. Global others Market, 2018 - 2030 (USD Million)
  • 5.3. Consumables
    • 5.3.1. Global consumables Market for Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)
  • 5.4. Software
    • 5.4.1. Global software Market for Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)
    • 5.4.2. Bioinformatics Tools
      • 5.4.2.1. Global bioinformatics tools Market for Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)
    • 5.4.3. Imaging Tools
      • 5.4.3.1. Global imaging tools Market for Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)
    • 5.4.4. Storage and Management Databases
      • 5.4.4.1. Global storage and management databases Market for Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Spatial Genomics & Transcriptomics Market: End-use Movement Analysis
  • 6.2. Translational Research
    • 6.2.1. Global spatial genomics & transcriptomics-based translational research market, 2018 - 2030 (USD Million)
  • 6.3. Academic Customers
    • 6.3.1. Global spatial genomics & transcriptomics-based academic customers market, 2018 - 2030 (USD Million)
  • 6.4. Diagnostic Customers
    • 6.4.1. Global spatial genomics & transcriptomics-based diagnostic customers market, 2018 - 2030 (USD Million)
  • 6.5. Pharmaceutical Manufacturer
    • 6.5.1. Global spatial genomics & transcriptomics-based pharmaceutical manufacturer market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Spatial Genomics & Transcriptomics Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. U.S. Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Canada Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. UK Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Germany Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. France Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Italy Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Spain Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Denmark Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Sweden Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Norway Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Japan Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. China Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. India Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Australia Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Thailand Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. South Korea Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Brazil Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Mexico Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Argentina Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. South Africa Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Saudi Arabia Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. UAE Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Kuwait Spatial Genomics & Transcriptomics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Natera, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. 10x Genomics
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Dovetail Genomics
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Illumina, Inc.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. S2 Genomics, Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Nanostring Technologies, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Seven Bridges Genomics
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Horizon Discovery Group plc
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Bio-Techne
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 3 Global Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 4 Global Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 5 Global Spatial Genomics & Transcriptomics Market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Spatial Genomics & Transcriptomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 8 North America Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 9 North America Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 Canada Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 Canada Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 16 Europe Spatial Genomics & Transcriptomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Europe Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 Europe Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 20 UK Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 UK Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 UK Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 23 Germany Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Germany Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Germany Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 France Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 France Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 France Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 Italy Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Italy Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 Italy Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 32 Spain Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 33 Spain Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Spain Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 35 Denmark Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 Denmark Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 38 Sweden Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Sweden Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40 Sweden Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 41 Norway Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Norway Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 43 Norway Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Spatial Genomics & Transcriptomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 48 Japan Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 Japan Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 50 Japan Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 51 China Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 China Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 China Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 54 India Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 India Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 56 India Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 57 Australia Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 Australia Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 59 Australia Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 60 Thailand Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Thailand Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Thailand Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 63 South Korea Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 South Korea Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 65 South Korea Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 66 Latin America Spatial Genomics & Transcriptomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 67 Latin America Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 Latin America Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Latin America Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 Brazil Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 Brazil Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 Brazil Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 73 Mexico Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 74 Mexico Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 75 Mexico Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 Argentina Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Spatial Genomics & Transcriptomics Market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 83 South Africa Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 South Africa Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 South Africa Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 89 UAE Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 UAE Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 91 UAE Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain - based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Spatial genomics & transcriptomics market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global spatial genomics & transcriptomics market: Product movement analysis
  • Fig. 15 Global spatial genomics & transcriptomics market, for instruments, 2018 - 2030 (USD Million)
  • Fig. 16 Global spatial genomics & transcriptomics market, for automated, 2018 - 2030 (USD Million)
  • Fig. 17 Global spatial genomics & transcriptomics market, for semi - automated, 2018 - 2030 (USD Million)
  • Fig. 18 Global spatial genomics & transcriptomics market, for manual, 2018 - 2030 (USD Million)
  • Fig. 19 Global spatial genomics & transcriptomics market, for sequencing platforms, 2018 - 2030 (USD Million)
  • Fig. 20 Global spatial genomics & transcriptomics market, for IHC, 2018 - 2030 (USD Million)
  • Fig. 21 Global spatial genomics & transcriptomics market, for microscopy, 2018 - 2030 (USD Million)
  • Fig. 22 Global spatial genomics & transcriptomics market, for flow cytometry, 2018 - 2030 (USD Million)
  • Fig. 23 Global spatial genomics & transcriptomics market, for mass spectrometry, 2018 - 2030 (USD Million)
  • Fig. 24 Global spatial genomics & transcriptomics market, for others, 2018 - 2030 (USD Million)
  • Fig. 25 Global spatial genomics & transcriptomics market, for consumables, 2018 - 2030 (USD Million)
  • Fig. 26 Global spatial genomics & transcriptomics market, for software, 2018 - 2030 (USD Million)
  • Fig. 27 Global spatial genomics & transcriptomics market, for bioinformatics tools, 2018 - 2030 (USD Million)
  • Fig. 28 Global spatial genomics & transcriptomics market, for imaging tools, 2018 - 2030 (USD Million)
  • Fig. 29 Global spatial genomics & transcriptomics market, for storage and management databases, 2018 - 2030 (USD Million)
  • Fig. 30 Global spatial genomics & transcriptomics market: Technology movement analysis
  • Fig. 31 Global spatial genomics & transcriptomics market, for spatial transcriptomics, 2018 - 2030 (USD Million)
  • Fig. 32 Global spatial genomics & transcriptomics market, for sequencing - based methods, 2018 - 2030 (USD Million)
  • Fig. 33 Global spatial genomics & transcriptomics market, for LCM methods, 2018 - 2030 (USD Million)
  • Fig. 34 Global spatial genomics & transcriptomics market, for FFPE tissue samples, 2018 - 2030 (USD Million)
  • Fig. 35 Global spatial genomics & transcriptomics market, for other Laser Capture Microdissection, 2018 - 2030 (USD Million)
  • Fig. 36 Global spatial genomics & transcriptomics market, for TIVA, 2018 - 2030 (USD Million)
  • Fig. 37 Global spatial genomics & transcriptomics market, for in - situ sequencing, 2018 - 2030 (USD Million)
  • Fig. 38 Global spatial genomics & transcriptomics market, for microtomy sequencing, 2018 - 2030 (USD Million)
  • Fig. 39 Global spatial genomics & transcriptomics market, for IHC sequencing, 2018 - 2030 (USD Million)
  • Fig. 40 Global spatial genomics & transcriptomics market, for microscopy - based RNA imaging technologies, 2018 - 2030 (USD Million)
  • Fig. 41 Global spatial genomics & transcriptomics market, for smFISH, 2018 - 2030 (USD Million)
  • Fig. 42 Global spatial genomics & transcriptomics market, for padlock probes/rolling circle amplification, 2018 - 2030 (USD Million)
  • Fig. 43 Global spatial genomics & transcriptomics market, for branched DNA probes, 2018 - 2030 (USD Million)
  • Fig. 44 Global spatial genomics & transcriptomics market, for spatial genomics, 2018 - 2030 (USD Million)
  • Fig. 45 Global spatial genomics & transcriptomics market, for FISH, 2018 - 2030 (USD Million)
  • Fig. 46 Global spatial genomics & transcriptomics market, for microscopy - based Live DNA imaging, 2018 - 2030 (USD Million)
  • Fig. 47 Global spatial genomics & transcriptomics market, for genome perturbation tools, 2018 - 2030 (USD Million)
  • Fig. 48 Global spatial genomics & transcriptomics market, for massively - parallel sequencing, 2018 - 2030 (USD Million)
  • Fig. 49 Global spatial genomics & transcriptomics market, for biochemical techniques, 2018 - 2030 (USD Million)
  • Fig. 50 Global spatial genomics & transcriptomics market, for other spatial genomic technique, 2018 - 2030 (USD Million)
  • Fig. 51 Global spatial genomics & transcriptomics market: End - use movement analysis
  • Fig. 52 Global spatial genomics & transcriptomics market, for translational research, 2018 - 030 (USD Million)
  • Fig. 53 Global spatial genomics & transcriptomics market, for academic customers, 2018 - 030 (USD Million)
  • Fig. 54 Global spatial genomics & transcriptomics market, for diagnostic customers, 2018 - 030 (USD Million)
  • Fig. 55 Global spatial genomics & transcriptomics market, for pharmaceutical manufacturer, 2018 - 030 (USD Million)
  • Fig. 56 Regional marketplace: Key takeaways
  • Fig. 57 Regional outlook, 2022 & 2030
  • Fig. 58 Global spatial genomics & transcriptomics market: Region movement analysis
  • Fig. 59 North America spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 60 U.S. spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 61 Canada spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 62 Europe spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 63 Germany spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 64 UK spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 65 France spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 66 Italy spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 67 Spain spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 68 Denmark spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 69 Sweden spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 70 Norway spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 71 Asia Pacific spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 72 Japan spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 73 China spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 74 India spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 75 Australia spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 76 South Korea spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 77 Thailand spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 78 Latin America spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 79 Brazil spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 80 Mexico spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 81 Argentina spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 82 Middle East and Africa spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 83 South Africa spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 84 Saudi Arabia spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 85 UAE spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 86 Kuwait spatial genomics & transcriptomics market, 2018 - 2030 (USD Million)